191 related articles for article (PubMed ID: 38466550)
1. In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds.
Ramos MLM; Almeida-Silva F; de Souza Rabello VB; Nahal J; Figueiredo-Carvalho MHG; Bernardes-Engemann AR; Poester VR; Xavier MO; Meyer W; Zancopé-Oliveira RM; Frases S; Almeida-Paes R
Braz J Microbiol; 2024 Jun; 55(2):1359-1368. PubMed ID: 38466550
[TBL] [Abstract][Full Text] [Related]
2. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
[TBL] [Abstract][Full Text] [Related]
3. Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug.
Poester VR; Munhoz LS; Larwood D; Martinez M; Stevens DA; Xavier MO
Med Mycol; 2021 Apr; 59(4):345-349. PubMed ID: 32634218
[TBL] [Abstract][Full Text] [Related]
4. Sporotrichosis Caused by Non-Wild Type
Bernardes-Engemann AR; Tomki GF; Rabello VBS; Almeida-Silva F; Freitas DFS; Gutierrez-Galhardo MC; Almeida-Paes R; Zancopé-Oliveira RM
Front Cell Infect Microbiol; 2022; 12():893501. PubMed ID: 35694546
[TBL] [Abstract][Full Text] [Related]
5. Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine.
Almeida-Paes R; Figueiredo-Carvalho MH; Brito-Santos F; Almeida-Silva F; Oliveira MM; Zancopé-Oliveira RM
PLoS One; 2016; 11(3):e0152796. PubMed ID: 27031728
[TBL] [Abstract][Full Text] [Related]
6. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
[TBL] [Abstract][Full Text] [Related]
7. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.
Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M
Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Song Y; Li S; Shi Y; Zhao L; Cui Y; Yao L; Zhen Y; Chen R; Cui Y
Braz J Microbiol; 2021 Mar; 52(1):81-90. PubMed ID: 32557246
[TBL] [Abstract][Full Text] [Related]
9. Sporotrichosis caused by Sporothrix brasiliensis in Argentina: Case report, molecular identification and in vitro susceptibility pattern to antifungal drugs.
Etchecopaz AN; Lanza N; Toscanini MA; Devoto TB; Pola SJ; Daneri GL; Iovannitti CA; Cuestas ML
J Mycol Med; 2020 Apr; 30(1):100908. PubMed ID: 31732417
[TBL] [Abstract][Full Text] [Related]
10. Studies in Phylogeny, Development of Rapid IdentificationMethods, Antifungal Susceptibility, and Growth Rates of Clinical Strains of Sporothrix schenckii Complex in Japan.
Suzuki R; Yikelamu A; Tanaka R; Igawa K; Yokozeki H; Yaguchi T
Med Mycol J; 2016; 57(3):E47-57. PubMed ID: 27581775
[TBL] [Abstract][Full Text] [Related]
11. Anti-Sporothrix activity of ibuprofen combined with antifungal.
Borba-Santos LP; Nucci M; Ferreira-Pereira A; Rozental S
Braz J Microbiol; 2021 Mar; 52(1):101-106. PubMed ID: 32617835
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Córdoba S; Isla G; Szusz W; Vivot W; Hevia A; Davel G; Canteros CE
Mycoses; 2018 Jul; 61(7):441-448. PubMed ID: 29500853
[TBL] [Abstract][Full Text] [Related]
13. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.
Rodrigues AM; de Hoog GS; de Cássia Pires D; Brihante RS; Sidrim JJ; Gadelha MF; Colombo AL; de Camargo ZP
BMC Infect Dis; 2014 Apr; 14():219. PubMed ID: 24755107
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil.
Brilhante RS; Rodrigues AM; Sidrim JJ; Rocha MF; Pereira SA; Gremião ID; Schubach TM; de Camargo ZP
Med Mycol; 2016 Mar; 54(3):275-9. PubMed ID: 26591009
[TBL] [Abstract][Full Text] [Related]
17. Antifungal resistance on Sporothrix species: an overview.
Waller SB; Dalla Lana DF; Quatrin PM; Ferreira MRA; Fuentefria AM; Mezzari A
Braz J Microbiol; 2021 Mar; 52(1):73-80. PubMed ID: 32476087
[TBL] [Abstract][Full Text] [Related]
18. Pentamidine inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents.
Brilhante RS; Pereira VS; Oliveira JS; Lopes RG; Rodrigues AM; Camargo ZP; Pereira-Neto WA; Castelo-Branco DS; Cordeiro RA; Sidrim JJ; Rocha MF
Future Microbiol; 2018 Aug; 13():1129-1140. PubMed ID: 30113216
[TBL] [Abstract][Full Text] [Related]
19.
Almeida-Silva F; Coelho RA; Bernardes-Engemann AR; Fichman V; Freitas DF; Galhardo MC; Corrêa-Junior D; Frases S; Zancopé-Oliveira RM; Almeida-Paes R
Future Microbiol; 2023 Nov; 18():1041-1048. PubMed ID: 37721514
[TBL] [Abstract][Full Text] [Related]
20. Clotrimazole is highly effective in vitro against feline Sporothrix brasiliensis isolates.
Gagini T; Borba-Santos LP; Messias Rodrigues A; Pires de Camargo Z; Rozental S
J Med Microbiol; 2017 Nov; 66(11):1573-1580. PubMed ID: 28984226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
